Sale!

Adequan Equine Injectable

Mfg. Price: $43.00$399.00
Add to cart for Express Vet Pharmacy price

Adequan Equine Injectable is an intramuscular treatment for non-infectious degenerative and/or traumatic joint dysfunction in horses.

Clear
SKU: N/A Categories: , , Tag: Prescription Required

Description

Adequan Equine Injectable is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. For intramuscular use in horses. Made by Luitpold.

Additional information

Weight N/A
Dimensions N/A
Dosage

Single Dose – 5 ml, Multi Dose – 50 ml

Package Size

1 ct, 7 ct

More Details

Adequan Equine Injectable requires a prescription from your veterinarian.

Polysulfated Glycosaminoglycan is chemically similar to the glycosaminoglycans in articular cartilage matrix. PSGAG is a potent proteolytic enzyme inhibitor and diminishes the loss of cartilage matrix components. PSGAG improves joint function by reducing synovial fluid protein levels and increasing synovial fluid hyaluronic acid concentration in traumatized equine joints.

Formulations

Single-Dose 100mg/ml 5 ml vial - single vial or box of 7 vials  OR
Multi-Dose 100 mg/ml - 50 ml vial.

Administration

The recommended dose of Adequan® i.m. Multi-Dose in horses is 500 mg every 4 days for 28 days intramuscularly. The injection site must be thoroughly cleansed prior to injection. Do not mix Adequan® i.m. with other drugs or solvents.

Precautions

Do not use in horses intended for human consumption.

Not for use in humans.

Keep this and all medications out of the reach of children.

The safe use of Adequan® i.m. in horses used for breeding purposes, during pregnancy, or in lactating mares has not been evaluated.

Manufacturer Product Information

LUITPOLD PHARMACEUTICALS, INC.
Animal Health Division
ONE LUITPOLD DRIVE, P.O. BOX 9001, SHIRLEY, NY, 11967
Telephone: 631-924-4000
Order Desk: 800-458-0163
Technical Service: 631-924-4000
Fax: 631-205-2125
Website: www.adequan.com

Every effort has been made to ensure the accuracy of the information published. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the USA product label or package insert.

ADEQUAN® I.M. SINGLE DOSE

Luitpold

Brand of Polysulfated Glycosaminoglycan (PSGAG)

Solution 500 mg/5 mL

For Intramuscular Use In Horses

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

DESCRIPTION: Each 5 milliliters of Adequan® i.m. contains 500 mg of Polysulfated Glycosaminoglycan and Water for Injection q.s. Sodium Hydroxide and/or Hydrochloric Acid added when necessary to adjust pH. Sodium Chloride may be added to adjust tonicity.

PHARMACOLOGY: Polysulfated Glycosaminoglycan is chemically similar to the glycosaminoglycans in articular cartilage matrix. PSGAG is a potent proteolytic enzyme inhibitor and diminishes or reverses the pathologic processes of traumatic or degenerative joint disease which result in a net loss of cartilage matrix components. PSGAG improves joint function by reducing synovial fluid protein levels and increasing synovial fluid hyaluronic acid concentration in traumatized equine carpal and hock joints.

INDICATIONS: Adequan® i.m. is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

DOSAGE AND ADMINISTRATION: The recommended dose of Adequan® i.m. in horses is 500 mg every 4 days for 28 days intramuscularly. The injection site must be thoroughly cleansed prior to injection. Do not mix Adequan® i.m. with other drugs or solvents.

CONTRAINDICATIONS: There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan.

WARNINGS: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children.

PRECAUTIONS: The safe use of Adequan® i.m. in horses used for breeding purposes, during pregnancy, or in lactating mares has not been evaluated.

ANIMAL SAFETY: Toxicity studies were conducted in horses. Doses as high as 2,500 mg were administered intramuscularly to 6 horses twice a week for 12 weeks. This dosage is 5 times the recommended dosage and 3 times the recommended therapeutic regimen. Clinical observations revealed no soreness or swelling at the injection site or in the affected joint. No animal had any clinical or laboratory evidence of toxicity.

STORAGE CONDITIONS: Store at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F) (See USP Controlled Room Temperature). Discard unused portion. Dispose of spent needles in accordance with all federal, state and local environmental laws.

HOW SUPPLIED: Adequan® i.m. solution, 500 mg/5 mL is available in 5 mL glass vials, packaged in boxes of 7.

STORAGE CONDITIONS

Store at controlled room temperature up to 25°C (77°F) (See USP). Discard unused portion.

LUITPOLD PHARMACEUTICALS, INC., Animal Health Division, Shirley, NY 11967

(631) 924-4000

(800) 458-0163

Made in U.S.A.

IN 99501

Rev. 10/08

MG #7560

NADA #140-901, Approved by FDA

CPN: 1039002.7

Reviews

There are no reviews yet.

Be the first to review “Adequan Equine Injectable”